Hair Loss
16
 min read

Shampoo for Thinning Hair and Hair Loss: UK Evidence Guide

Written by
Bolt Pharmacy
Published on
13/3/2026

Shampoo for thinning hair and hair loss is one of the first products many people in the UK reach for when they notice their hair becoming finer or sparser. With hundreds of options on the market — from caffeine-based formulas to ketoconazole shampoos — it can be difficult to separate genuine clinical benefit from clever marketing. This article explains the common causes of hair thinning, what to look for in a shampoo, which ingredients have credible evidence behind them, and how shampoo fits alongside NHS-recognised treatments such as minoxidil and finasteride.

Summary: No shampoo can reverse hair loss on its own, but certain formulations can support scalp health and complement NHS-recognised treatments such as minoxidil for thinning hair and hair loss.

  • The most common cause of hair loss in UK men is androgenetic alopecia (male-pattern baldness), driven by sensitivity to DHT; women experience a similar diffuse thinning pattern.
  • Ketoconazole 2% shampoo (Nizoral) is licensed for dandruff and seborrhoeic dermatitis, not as a hair loss treatment; caffeine-based shampoos lack robust clinical evidence for hair regrowth.
  • Zinc pyrithione is no longer permitted in cosmetic shampoos in the UK or EU under retained cosmetics regulation; most dandruff shampoos have reformulated.
  • Minoxidil (available OTC as Regaine 2% or 5%) is the most widely used topical treatment for pattern hair loss; results take three to six months and treatment must be continued indefinitely.
  • Finasteride 1 mg is a prescription-only oral treatment for men; the MHRA has issued safety updates regarding sexual side effects and psychiatric risks, including depression and suicidal ideation.
  • Consult a GP promptly if hair loss is sudden, patchy, accompanied by scalp inflammation, or associated with systemic symptoms such as fatigue or unexplained weight change.

Am I eligible for weight loss injections?

60-second quiz
Eligibility checker

Find out whether you might be eligible!

Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).

  • No commitment — just a quick suitability check
  • Takes about 1 minute to complete

Common Causes of Thinning Hair and Hair Loss in the UK

The most common cause of hair loss in UK men is androgenetic alopecia, driven by DHT sensitivity; in women, diffuse crown thinning is typical. Other causes include telogen effluvium, nutritional deficiencies, thyroid disorders, and scalp conditions.

Hair loss is a widespread concern in the UK, affecting both men and women across all age groups. Understanding the underlying cause is essential before selecting any treatment, including a shampoo for thinning hair and hair loss. The most common cause in men is androgenetic alopecia (male-pattern baldness), a hereditary condition driven by sensitivity to dihydrotestosterone (DHT), a derivative of testosterone. In women, a similar process — female-pattern hair loss — can occur, often presenting as diffuse thinning across the crown rather than a receding hairline.

Beyond genetics, several other factors contribute to hair thinning:

  • Telogen effluvium — a temporary, stress-related shedding often triggered by illness, surgery, significant weight loss, or emotional trauma

  • Nutritional deficiencies — particularly low iron, ferritin, vitamin D, or B12; a GP can confirm whether a deficiency is present via a blood test before supplementation is considered

  • Thyroid disorders — both hypothyroidism and hyperthyroidism can disrupt the hair growth cycle

  • Alopecia areata — an autoimmune condition causing patchy hair loss, affecting approximately 2% of people in the UK at some point in their lives

  • Scalp conditions — such as seborrhoeic dermatitis or scalp psoriasis, which can affect follicle health

Certain medications may also contribute to hair thinning as a side effect, including anticoagulants, antidepressants, hormonal contraceptives, beta-blockers, retinoids (such as isotretinoin), antithyroid drugs, and chemotherapy agents. This list is not exhaustive; always discuss any new or worsening hair loss with your GP if you have recently started a new medicine.

When to seek prompt medical advice

Consult a GP promptly if you notice any of the following:

  • Rapid or sudden hair loss, particularly with scalp pain, inflammation, pustules, or scarring

  • Patchy hair loss with broken hairs, scaling, or swollen lymph nodes — especially in children, where tinea capitis (scalp ringworm) should be excluded

  • Loss of eyebrows or eyelashes alongside scalp hair loss

  • Hair loss accompanied by systemic symptoms such as fatigue, unexplained weight change, or skin changes

  • In women: signs of hyperandrogenism such as acne, hirsutism (excess facial or body hair), or menstrual irregularity, which warrant an androgen profile and further investigation

  • Hair loss in children of any pattern

A GP can arrange relevant blood tests — typically including a full blood count (FBC), ferritin, and thyroid-stimulating hormone (TSH), with B12, folate, vitamin D, and androgen levels where clinically indicated — to identify treatable medical causes. Scarring alopecia or suspected tinea capitis in children warrants early referral to a dermatologist. For other forms of hair loss, a GP can refer to a NHS dermatologist where appropriate. Early investigation generally leads to better outcomes.

Sources: NHS Hair loss (alopecia); NICE CKS: Alopecia – male pattern hair loss; NICE CKS: Alopecia areata; Primary Care Dermatology Society (PCDS) guidance on hair loss; British Association of Dermatologists (BAD) patient information.

Ingredient / Treatment Type Licensed Indication (MHRA/UK) Evidence for Hair Loss Key Cautions
Ketoconazole 2% (e.g., Nizoral) Antifungal shampoo (Pharmacy medicine) Dandruff, seborrhoeic dermatitis — not licensed for hair loss Small studies suggest modest density improvement; low-quality evidence Use per licensed instructions; benefit likely via scalp inflammation control
Caffeine-based shampoos (e.g., Alpecin) Cosmetic shampoo None — no MHRA or NICE-recognised indication In vitro data only; no robust clinical evidence in humans Not a treatment for androgenetic alopecia
Biotin / keratin shampoos Cosmetic shampoo None Topical biotin unlikely to absorb meaningfully; cosmetic benefit only Not a treatment for hair loss; oral biotin only if deficiency confirmed
Piroctone olamine, selenium sulphide, coal tar, salicylic acid Medicated / cosmetic shampoo Dandruff, seborrhoeic dermatitis Established evidence for scalp health; supports follicle environment Zinc pyrithione no longer permitted in UK/EU cosmetic shampoos
Minoxidil 2% / 5% (e.g., Regaine) Topical solution / foam (OTC) Male and female pattern hair loss Most evidence-based OTC option; results in 3–6 months; must continue indefinitely Avoid in pregnancy/breastfeeding; initial shedding common; stop if dermatitis occurs
Finasteride 1 mg (Propecia) Oral prescription-only medicine (POM) Male androgenetic alopecia only Reduces DHT; effective for male pattern hair loss with continued use Not for women of childbearing potential; MHRA warnings: sexual dysfunction, depression, suicidal ideation; report via Yellow Card
Corticosteroid injections / topical immunotherapy NHS specialist treatment Alopecia areata (dermatologist-led) NHS-recognised; availability varies across trusts Requires GP referral to NHS dermatologist

What to Look for in a Shampoo for Thinning Hair

No shampoo can reverse genetic hair loss, but gentle, sulphate-free formulas with evidence-backed active ingredients can support scalp health and reduce breakage. Prioritise products with peer-reviewed evidence or a licensed indication over marketing claims such as 'clinically validated'.

Choosing the right shampoo for thinning hair requires a clear understanding of what these products can — and cannot — do. No shampoo can reverse genetic hair loss or regrow hair on its own. However, certain formulations can support scalp health, reduce breakage, improve the cosmetic appearance of hair density, and help maintain a healthy environment for existing follicles.

When evaluating a shampoo for thinning hair and hair loss, consider the following:

  • Scalp-cleansing efficacy — regular, gentle cleansing helps remove excess sebum and product build-up, supporting overall scalp health

  • Gentle, sulphate-free formulas — harsh detergents such as sodium lauryl sulphate (SLS) can strip the scalp of natural oils, potentially worsening irritation and hair fragility in some individuals

  • Ingredients with published clinical evidence — prioritise products where active ingredients have been evaluated in peer-reviewed studies or carry a licensed indication, rather than relying on marketing claims alone (see the next section)

  • Avoidance of known sensitisers — fragrance allergens and certain preservatives, such as methylisothiazolinone (MI) and methylchloroisothiazolinone (MCI), are recognised causes of contact dermatitis and may aggravate sensitive or inflamed scalps

It is also worth considering your hair type and any co-existing scalp conditions. For example, someone with seborrhoeic dermatitis may benefit from a medicated shampoo containing an appropriate active ingredient (see below), whilst someone with fine, limp hair may prioritise a volumising formula with protein-based ingredients.

When assessing product claims, note that terms such as 'dermatologist-tested' and 'clinically validated' are marketing descriptions rather than regulatory standards. Look instead for products with peer-reviewed evidence or a licensed indication for your specific scalp condition. If you are unsure which product is appropriate, a pharmacist or GP can offer guidance. Note that trichologists are not medically regulated and are not part of NHS referral pathways.

Sources: PCDS guidance on seborrhoeic dermatitis and scalp psoriasis; NHS pages on dandruff and scalp psoriasis.

Shampoos Available in the UK: Ingredients and Evidence

Ketoconazole 2% shampoo has the strongest evidence base for scalp inflammation but is not MHRA-licensed for hair loss; caffeine and biotin shampoos lack robust clinical evidence for hair regrowth. Zinc pyrithione is no longer permitted in UK cosmetic shampoos.

The UK market offers a wide range of shampoos marketed for thinning hair, but the quality of evidence supporting their ingredients varies considerably. Below is an overview of the most commonly used active ingredients and what the current evidence suggests.

Ketoconazole (e.g., Nizoral 2% shampoo) Ketoconazole is an antifungal agent available as a pharmacy (P) medicine in the UK. Its licensed indications are dandruff and seborrhoeic dermatitis; it is not licensed by the MHRA as a hair loss treatment. Some small clinical studies have suggested modest improvements in hair density with regular use, but these findings are limited in scale and quality, and any benefit is likely related to control of underlying scalp inflammation rather than a direct anti-androgenic effect. It should be used according to the licensed instructions on the product label or as directed by a pharmacist.

Caffeine-based shampoos (e.g., Alpecin) Caffeine-based shampoos are widely available in UK pharmacies and supermarkets. Laboratory (in vitro) studies suggest caffeine may counteract the inhibitory effects of testosterone on hair follicle growth in cell models. However, clinical evidence in humans is limited and of low certainty, and there is no MHRA-approved or NICE-recognised indication for hair regrowth. These products should not be considered a treatment for androgenetic alopecia.

Biotin-enriched and keratin-fortified shampoos These are popular for improving hair strength and reducing breakage. Whilst biotin deficiency is associated with hair loss, topical biotin applied in a shampoo is unlikely to be absorbed in clinically meaningful quantities. These products may improve the cosmetic appearance of hair but are not a treatment for hair loss.

Shampoos for dandruff and scalp inflammation Maintaining a healthy scalp is important for follicle health. For dandruff and seborrhoeic dermatitis, ingredients with an established evidence base and permitted status in UK cosmetic or medicinal products include piroctone olamine, selenium sulphide, coal tar, salicylic acid, and climbazole. Ketoconazole 2% shampoo (a P medicine) is also an option for seborrhoeic dermatitis.

Importantly, zinc pyrithione is no longer permitted as an ingredient in cosmetic shampoos in the UK or EU under retained cosmetics regulation (UK Cosmetics Regulation, derived from EU Regulation 1223/2009, Annex II). Most UK dandruff shampoos have reformulated accordingly. Check current product labels and, if in doubt, ask a pharmacist.

No shampoo is currently approved by the MHRA or recommended by NICE as a standalone treatment for androgenetic alopecia. When selecting a product, prioritise those with peer-reviewed evidence or a licensed indication over anecdotal testimonials, and be cautious of exaggerated claims.

Sources: EMC SmPC: Nizoral (ketoconazole) 2% shampoo; UK Cosmetics Regulation/OPSS guidance on zinc pyrithione; NICE CKS and PCDS on dandruff and seborrhoeic dermatitis.

Other NHS-Recognised Treatments to Use Alongside Shampoo

Minoxidil (Regaine) and prescription finasteride are the main NHS-recognised treatments for androgenetic alopecia and should be used alongside, not replaced by, a suitable shampoo. Both require long-term use and carry important safety considerations discussed with a GP.

Whilst a shampoo for thinning hair and hair loss can support scalp health and hair appearance, it is most effective when used as part of a broader management plan. The NHS and NICE recognise several evidence-based treatments for hair loss, particularly androgenetic alopecia, which may be used alongside a suitable shampoo.

Minoxidil Minoxidil is the most widely used topical treatment for both male and female pattern hair loss. It is available over the counter in the UK as a 2% or 5% solution or foam (e.g., Regaine). Its precise mechanism is not fully understood, but it is thought to prolong the anagen (growth) phase of the hair cycle, in part through potassium channel opening and increased blood flow to follicles. Results typically take three to six months to become apparent, and treatment must be continued indefinitely to maintain any benefit — hair loss will resume if treatment is stopped.

Key safety points for minoxidil:

  • An initial increase in shedding may occur in the first few weeks of use; this is usually temporary

  • Scalp irritation or contact dermatitis can occur; discontinue use and consult a pharmacist or GP if this happens

  • Minoxidil should not be used during pregnancy or whilst breastfeeding

  • Avoid contact with broken, inflamed, or infected skin

  • Follow the manufacturer's instructions carefully and do not exceed the recommended dose

Finasteride (Propecia) Finasteride 1 mg is a prescription-only oral medication for men with androgenetic alopecia. It works by inhibiting the enzyme 5-alpha reductase, thereby reducing DHT levels at the scalp. It is not recommended for women of childbearing potential due to the risk of harm to a male foetus; women who are pregnant or may become pregnant must not handle crushed or broken tablets.

The MHRA has issued safety updates regarding finasteride. Patients and prescribers should be aware of the following risks:

  • Sexual side effects, including reduced libido, erectile dysfunction, and ejaculation disorders — these may persist after stopping treatment in some men (post-finasteride syndrome)

  • Psychiatric effects, including depression and, rarely, suicidal ideation — patients should seek immediate medical help and stop taking finasteride if they experience mood changes, depression, or thoughts of self-harm

Patients should discuss these risks fully with their GP before starting finasteride. Any suspected side effects from finasteride or any other medicine should be reported to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.

Alopecia areata For those with alopecia areata, the NHS may offer corticosteroid injections, topical immunotherapy, or referral to a dermatologist. More advanced treatments are specialist-led and availability varies across NHS trusts.

Nutritional optimisation Addressing confirmed deficiencies in iron, vitamin D, or B12 through diet or supplementation is an important adjunct where blood tests confirm a deficiency. Supplementation is not recommended without confirmed deficiency.

Seeking help If hair loss is causing significant psychological distress, speak to your GP, who can refer you to a NHS dermatologist for assessment and management. Psychological support, including NHS Talking Therapies, may also be appropriate. Trichologists are not medically regulated and are not part of NHS referral pathways. Early intervention generally leads to better outcomes.

Sources: NHS Hair loss (alopecia); NICE CKS: Alopecia – male pattern hair loss; NICE CKS: Alopecia areata; EMC SmPC: Regaine (minoxidil); EMC SmPC: Propecia (finasteride 1 mg); MHRA Drug Safety Update on finasteride (psychiatric and sexual side effects); BAD patient information on male and female pattern hair loss.

Frequently Asked Questions

Can a shampoo for thinning hair actually stop hair loss?

No shampoo can stop genetic hair loss or regrow hair on its own. Shampoos for thinning hair can support scalp health, reduce breakage, and improve the cosmetic appearance of density, but they are not a substitute for evidence-based treatments such as minoxidil or finasteride.

Is Nizoral shampoo good for hair loss?

Nizoral (ketoconazole 2%) is licensed in the UK for dandruff and seborrhoeic dermatitis, not as a hair loss treatment. Some small studies suggest modest improvements in hair density, but the evidence is limited and any benefit is likely due to reducing scalp inflammation rather than a direct effect on hair follicles.

What is the difference between using a shampoo for thinning hair and using minoxidil?

Minoxidil (Regaine) is a clinically proven, over-the-counter topical treatment that prolongs the hair growth phase and is NHS-recognised for androgenetic alopecia, whereas shampoos for thinning hair primarily support scalp health and hair appearance. Minoxidil must be used continuously for at least three to six months to see results, and hair loss returns if treatment is stopped.

Are caffeine shampoos like Alpecin effective for hair loss?

Caffeine shampoos have shown some promise in laboratory studies, but clinical evidence in humans is limited and of low certainty. They are not approved by the MHRA or recommended by NICE as a treatment for androgenetic alopecia, so they should not replace proven treatments.

How do I get a prescription for finasteride for hair loss in the UK?

Finasteride 1 mg (Propecia) is a prescription-only medicine in the UK, so you will need to see your GP or a registered prescriber to obtain it. Your GP can assess whether it is appropriate for you, discuss the MHRA-highlighted risks including sexual and psychiatric side effects, and arrange any necessary monitoring.

Can women use the same shampoos and treatments for thinning hair as men?

Most shampoos for thinning hair are suitable for both men and women, but key treatments differ: finasteride is not recommended for women of childbearing potential due to the risk of harm to a male foetus, and minoxidil is available in lower concentrations specifically for women. Women experiencing hair thinning alongside symptoms such as acne, excess facial hair, or irregular periods should see their GP for further investigation.


Disclaimer & Editorial Standards

The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.

The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.

Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C

Text link

Bold text

Emphasis

Superscript

Subscript

Book a discovery call

and discuss your eligibility for the Fella Program

Book your free call